MoneyWorks4Me

Camlin Fine Sciences planning to raise funds up to Rs 250 crore

18 May 2018 Evaluate

Camlin Fine Sciences is planning to raise funds not exceeding Rs 250 crore by way of debt and QIP/GDR/ADR/FCCB/other securities linked to equity/ preference shares /any instrument or securities representing convertible securities. The meeting of the Board of Directors of the company is scheduled to be held on May 24, 2018, to consider the same.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).


Peers
Company Name CMP
Godrej Industries 1107.45
SRF 2561.00
BASF India 3607.50
Pidilite Inds. 1566.10
Tata Chemicals 693.50
View more..